Grant Sanderson teaches cannabis enthusiasts how to sell legal weed.

The regional manager, cannabis division, of Alcanna, which runs the Nova Cannabis chain of legal dispensaries in Ontario and Alberta, explains regulatory compliance, methods of consumption and the lineage of more than 50 different strains. He’s being doing this since June, and more than 200 people have graduated from his four-day program to become legal dealers or “budtenders.”

He’s never had to kick anyone out of class for being stoned.

Cannabis-infused beverages could soon be a big hit. Being able to drink a beverage, get a buzz, and not be hungover the next day could prove to be an easy sell to people who consume alcohol. While the segment hasn't taken off in the U.S. where beverages still represent a very small fraction of cannabis sales, that might not be the case for much longer.

You'll hear most of the big Canadian cannabis producers talk a lot about revenue growth. However, it's a different story when it comes to profits. In most cases, any reported profit for one of the five biggest Canadian producers will come with an asterisk: a paper profit fueled by a one-time gain rather than true operating profitability.

ParcelPal Technology Inc. ("ParcelPal" or the "Company"), (CSE: PKG) (FSE: PT0) (OTC: PTNYF) is pleased to announce that it secured a distribution agreement with one of the largest Canadian Federally Licensed producers in Canada, Aphria Inc. ("Aphria") (TSX: APHA) (NYSE: APHA) for delivery of medical cannabis to patients. 

Cannabis investors have had a rough ride in the last 12 months. Several stocks lost significant value due to regulatory issues and missing analyst target estimates. Cannabis stocks were overvalued and expensive.

Shares of Cronos Group (TSX:CRON)(NASDAQ:CRON) have fallen 46% since March 2019. Despite the recent pullback, the stock has returned a mind-blowing 1,825% since its IPO back in December 2014.

The cannabis market has experienced a seismic shift over the past few years. Sales have grown at an exponential rate, and many of the top firms in the sector have seen their share prices skyrocket. Thankfully, it isn’t too late for those looking to profit from this rare opportunity. The cannabis industry is projected to keep growing, both in North America and abroad.

Ontario has released results of its second lottery selecting 42 operators hoping to run cannabis shops in the province.

The Alcohol and Gaming Commission of Ontario (AGCO) said it received 4,684 applicants in the draw.

Unlike the first lottery held earlier this year, which faced criticism for not including a merit component, applications for the second draw were required to show evidence that they have secured retail space that could be used as a store if they are selected, and that they have enough capital to open it.

Those selected will have until Aug. 28 to pay licensing fees, and provide a letter of credit for $50,000 to the regulator.

Few news items this summer jolted the legalized cannabis industry quite like the termination of former co-CEO Bruce Linton from Canopy Growth Corp.

Tilray (TLRY) stock got a boost after the firm announced it has signed its first deal to supply marijuana from its EU campus. It is the first move in the Canadian firm's planned invasion of Europe.

The firm inked a $3.3 million initial supply agreement to deliver medical cannabis to German distributor Cannamedical Pharma from its new growth facility in Portugal. The delivery is expected to be completed in the fall.

"This is a significant milestone for Tilray as we ramp up our capacity to serve international markets and generate revenue from our EU campus through the end of 2019," Tilray CEO Brendan Kennedy said in a news release.

Cannabis stocks were broadly flat on Wednesday, after a drop on Tuesday and a rocky few months for the industry. 

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, was up 0.1% at 192.7 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF was up 0.2% to C$15.22, while the OTCQX Cannabis Index slipped 0.2% at 663.7 points.

Buds

FSD Pharma Inc (CSE:HUGE) (OTCQB:FSDDF) shares were soaring Wednesday after the firm announced the launch of its online ordering system to fill medicinal cannabis prescriptions.